Table 5 Respiratory and immune dysfunction
|  | TS1 Gly406Arg yes/total (%) n = 30 | TS2 Gly406Arg yes/total (%) n = 11 | Gly402Ser yes/total (%) n = 6 | Diagnosed nsLQT8 yes/total (%) n = 12 | Other yes/total (%) n = 28 | Correlation p-value |
|---|---|---|---|---|---|---|
Respiratory concerns | 13/29 (45) | 3/10 (30) | 1/6 (17) | 4/6 (67) | 9/20 (45) | 0.4695 |
 Early childhood respiratory concerns: | 10/24 (42) | 2/10 (20) | 0/6 (0) | 3/4 (75) | 8/10 (80) |  |
 Aspiration | 2/29 (7) | 1/10 (10) | 1/6 (17) | 0/4 (0) | 4/10 (40) |  |
 Frequent pneumonia | 10/21 (48) | 3/6 (50) | 1/6 (17) | 0/4 (0) | 6/10 (60) |  |
 Asthma | 7/23 (30) | 1/9 (11) | 0/6 (0) | 3/4 (75) | 1/10 (10) |  |
 Nebulizer treatments | 5/20 (25) | 1/9 (11) | 0/6 (0) | 3/4 (75) | 0/10 (0) |  |
 CRAP use | 1/6 (17) | --- | --- | --- | --- |  |
 Respiratory deaths | 1/7 (14) | 1/2 (50) | --- | --- | 2/3 (67) |  |
Frequent infections | 9/25 (36) | 5/11 (45) | 0/6 (0) | 9/11 (82) | 11/21 (52) | 0.0137 |
Delayed wound healing | 2/30 (6) | 1/9 (11) | 0/6 (0) | 2/9 (22) | 4/19 (23) | 0.0390 |